Noxxon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Satisfied Charges ₹ 3.00 M
About Noxxon Pharmaceuticals
Noxxon Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2021 (Three years and eight months 5 days old ). Its registered office is in Rupnagar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Bansal and Satish Bansal serve as directors at the Company.
Company Details
-
Location
Rupnagar, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239PB2021PTC053565
-
Company No.
053565
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jun 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Noxxon Pharmaceuticals Private Limited offer?
Noxxon Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Dietary Supplements, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Common Disease Medicines.
Who are the key members and board of directors at Noxxon Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Bansal
|
Director | 07-Jun-2021 | Current |
|
Satish Bansal
|
Director | 07-Jun-2021 | Current |
Financial Performance of Noxxon Pharmaceuticals.
Noxxon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noxxon Pharmaceuticals?
Unlock access to Noxxon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.00 M
₹3.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2024 | Hdfc Bank Limited | ₹4.00 M | Open |
| 19 Feb 2022 | Others | ₹3.00 M | Satisfied |
How Many Employees Work at Noxxon Pharmaceuticals?
Noxxon Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noxxon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noxxon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.